Affordable Access

deepdyve-link
Publisher Website

Serum levels of brain-derived neurotrophic factor and cortisol to sulfate of dehydroepiandrosterone molar ratio associated with clinical response to L-theanine as augmentation of antipsychotic therapy in schizophrenia and schizoaffective disorder patients.

Authors
  • Miodownik, Chanoch1
  • Maayan, Rachel
  • Ratner, Yael
  • Lerner, Vladimir
  • Pintov, Leonid
  • Mar, Maria
  • Weizman, Abraham
  • Ritsner, Michael S
  • 1 Division of Psychiatry, Faculty of Health Sciences Ben-Gurion University of the Negev, Ministry of Health Be'er-Sheva Mental Health Center, Be'er-Sheva, Israel. , (Israel)
Type
Published Article
Journal
Clinical neuropharmacology
Publication Date
Jan 01, 2011
Volume
34
Issue
4
Pages
155–160
Identifiers
DOI: 10.1097/WNF.0b013e318220d8c6
PMID: 21617527
Source
Medline
License
Unknown

Abstract

These preliminary results indicate that circulating BDNF and cortisol-to-DHEAS*100 molar ratio may be involved in the beneficial clinical effects of L-theanine as augmentation of antipsychotic therapy in schizophrenia and schizoaffective disorder patients.

Report this publication

Statistics

Seen <100 times